+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The search for the neurobiological basis of vulnerability to drug abuse: using microarrays to investigate the role of stress and individual differences



The search for the neurobiological basis of vulnerability to drug abuse: using microarrays to investigate the role of stress and individual differences



Neuropharmacology 47(Suppl. 1): 111-122



Basic neurobiological studies have led to great progress in our understanding of the mechanisms of action of drugs of abuse. Much has been learned about the brain response from the moment a psychoactive drug enters the organism onwards, including the psychological, neurobiological and peripheral effects of repeated drug administration, withdrawal and re-exposure. However, to relate this knowledge to the human experience requires further research on the antecedents of drug-taking behavior and the factors that predispose particular individuals to drug seeking and drug abuse. Thus, it is important to address several issues at the fundamental level: (1) Why are some individuals more vulnerable to drugs of abuse more than others? Is there a broader dimension or dimensions of emotional reactivity that contribute to this difference in vulnerability? (2) What is the effect of psychosocial stress on drug-seeking and drug-taking behavior, and are the effects distinct across individuals? (3) Since both drug-taking behavior and stress have sustained and pervasive effects on the brain, can we use microarrays to discern the "neural signature" or "neural phenotype" associated with these processes, and can we distinguish this signature across individuals with differing propensities to taking drugs? In the present paper, we summarize some of our early attempts at addressing these questions. We rely on animal studies aimed at characterizing the emotional and stress reactivity of rats with different propensities to self-administer drugs (high responders and low responders); we briefly describe the effect of a psychosocial stressor on these animals; we then detail a study using microarray technology aimed at investigating the "neural phenotype" associated with social defeat stress in the high vs. low responder animals. This "discovery" approach is used as a starting place for identifying novel mechanisms that might alter the vulnerability of different individuals to drug-seeking behavior. The power and limits of this approach, and its future directions, are discussed within this general framework.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012680837

Download citation: RISBibTeXText

PMID: 15464130

DOI: 10.1016/j.neuropharm.2004.07.021


Related references

Imaging genetics and the neurobiological basis of individual differences in vulnerability to addiction. Drug and Alcohol Dependence 123(Suppl. 1): S59-S71, 2012

Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annual Review of Pharmacology and Toxicology 36: 359-378, 1996

Spatial learning impairment induced by chronic stress is related to individual differences in novelty reactivity: search for neurobiological correlates. Psychoneuroendocrinology 29(2): 290-305, 2004

Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status. Psychopharmacology 189(1): 17-25, 2006

Social defeat protocol and relevant biomarkers, implications for stress response physiology, drug abuse, mood disorders and individual stress vulnerability: a systematic review of the last decade. Trends in Psychiatry and PsychoTherapy 37(2): 51-66, 2016

Individual differences in stress vulnerability: The role of gut pathobionts in stress-induced colitis. Brain Behavior and Immunity 64: 23-32, 2017

Neurobiological relationship between vulnerability to depression and to drug abuse In vivo microdialysis studies. Society for Neuroscience Abstracts 21(1-3): 1955, 1995

Individual differences in vulnerability to drug abuse: the high responders/low responders model. Cns and Neurological Disorders Drug Targets 5(5): 513-520, 2006

Individual Differences in Vulnerability to Drug Abuse: The High Responders/Low Responders Model. Cns & Neurological Disorders - Drug Targets 5(5): 513-520, 2006

Environmental regulation of the development of mesolimbic dopamine systems: A neurobiological mechanism for vulnerability to drug abuse?. Psychoneuroendocrinology 27(1-2): 127-138, 2002

Capturing Individual Differences: Challenges in Animal Models of Posttraumatic Stress Disorder and Drug Abuse. Biological Psychiatry 78(12): 816-818, 2015

The role of cAMP response element-binding proteins in mediating stress-induced vulnerability to drug abuse. International Review of Neurobiology 65: 147-178, 2005

The preeminent role of childhood abuse and neglect in vulnerability to major psychiatric disorders: toward elucidating the underlying neurobiological mechanisms. Journal of the American Academy of Child and Adolescent Psychiatry 53(4): 395-397, 2014

Sex differences in the vulnerability to drug abuse: a review of preclinical studies. Neuroscience and Biobehavioral Reviews 28(6): 533-546, 2004

Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules. Journal of Neuroscience 20(18): 6983-6988, 2000